معرفی
Jialing Xiang is a Professor of Biology at the Lewis College of Science and Letters, Illinois Institute of Technology. Her research focuses on molecular mechanisms underlying human diseases, including programed cell death, signaling pathways, and protein trafficking. She holds an M.D. from Xuzhou Medical University and a Ph.D. from the University of Alabama at Birmingham.
Her laboratory investigates pro-apoptotic Bcl-2 family proteins (e.g., Bax and Bad), uncovering novel isoforms like BaxΔ2 that serve as potential cancer therapy biomarkers. Key projects explore cross-talk between apoptotic pathways and inflammation/hormonal responses, aiming to identify therapeutic targets.
Recent work emphasizes nanopore-based DNA mutation detection and Ubl4A's role in actin dynamics/insulin signaling. Over 30 peer-reviewed publications highlight her contributions to apoptosis regulation, cancer biology, and signaling networks.
Expertise includes molecular cell biology techniques, protein interaction studies, and translational research bridging basic science to clinical applications. Currently leads initiatives in biomarker development and drug sensitivity mechanisms in cancer.
